SSGJ-705 Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1: 1Phase 2: 2

Top Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD.2
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1

Indications

Cancer3
Locally Advanced, Recurrent or Metastatic Malignancies2
Locally Advanced (Unresectable) or Metastatic Solid Tumors1

Other3 trials

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors

Phase 1

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

Phase 2

SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.